Skip to content
Catalyst

Curcuma longaFinding

Curcuma longa decreases HOMA-IR

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Turmeric consumption decreased serum levels of glucose, insulin, HOMA-IR and leptin (by 1.22, 17.69, 19.48 and 21.33% respectively, p < 0.05 for all) over 12 weeks compared with those variables in the placebo group.”
Quoted verbatim from Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.
This finding among the 63 findings on its endpoint

Curcuma longa

HOMA-IR

lowers

Who
46 adults with non-alcoholic fatty liver disease (21 males, 25 females), aged 20-60 years, BMI 24.9-40 kg/m2
Dose studied
six capsules daily (6 x 500 mg) for 12 weeks

Very limited evidencePMID 28443702 · 2017

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

Journal of the American College of Nutrition
What else it reported2 findings · 0 compounds · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M703TYP0G1SBKVK06BNDS7ZA